Search results

Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Michele De Bonis , Ottavio Alfieri Added: 3 years ago
Degenerative mitral regurgitation (MR) represents a rather common pathology, affecting 1–2% of the general population. In patients requiring surgery for this disease, mitral valve repair is the standard of care. Whenever feasible it is preferable to prosthetic replacement, as it provides better preservation of left ventricular (LV) function, higher survival, lower rates of thromboembolism and… View more

Vascular Disease and Surgery

Intervention
EuroPCR 22: Transcatheter Tricuspid Valve Repair with PASCAL System
Author(s): Stephan Baldus Added: 1 year ago
Prof Stephan Baldus (University of Köln Medical Center, DE) shares insights from the TriCLASP post-market study (NCT04614402). This postmarket clinical follow up study, presented at EuroPCR 2022, assessed the safety and effectiveness of the Edwards PASCAL Transcatheter Valve Repair System in transcatheter tricuspid valve repair. Discussion Points: 1. Unmet needs of patients with TR 2. Study… View more

Intervention
Author(s): Michael Hoebartner , Philipp Kiefer , Michael Andrew Borger , et al Added: 3 years ago
Mitral valve regurgitation (MR) is frequently induced by degenerative mitral valve (MV) disease and leads to leaflet prolapse. Therefore, valve repair is a well-proven surgical technique with excellent long-term outcomes.1–5 The risk of declining left ventricle (LV) function or LV enlargement and the development of atrial fibrillation or severe pulmonary hypertension due to chronic volume… View more

Intervention

Vascular Disease and Surgery
Author(s): Martin Swaans , Ben van den Branden , Marco Post , et al Added: 3 years ago
In Europe, mitral regurgitation (MR) is the second most common form of valvular heart disease needing surgery.1 Studies have shown that up to 50 % of patients with severe symptomatic MR are not referred to surgery, even if a surgical indication exists.1–3 Reasons for denying surgery include impaired left ventricular ejection fraction, a high operative risk, multiple comorbidities or advanced age… View more

Vascular Disease and Surgery

Imaging & Diagnostics
Author(s): Ottavio Alfieri , Michele De Bonis Added: 3 years ago
Despite the absence of randomised comparison, it is widely accepted that, when feasible, valve repair is the optimal surgical treatment in patients with severe degenerative mitral regurgitation (MR) due to the well documented advantages of such an approach over valve replacement in terms of perioperative mortality, preservation of postoperative left ventricular (LV) function and long-term… View more

Vascular Disease and Surgery

MI/ACS
Research Area(s) / Expertise: Job title: Professor of Cardiac Surgery, and Chief, Department of Cardiac Surgery
Prof Ottavio Alfieri is Senior Consultant at the Cardiothoracic Surgery Unit of San Raffaele Hospital, Milan, IT. He is the President of the "Alfieri Heart Foundation," established to support research and innovation at San Raffaele Hospital. From 1996 to 2017, he served as the Director of the Cardiothoracic Surgery Unit at San Raffaele Hospital in Milan and held the position of Professor of… View more
Dr Gilbert Tang is Surgical Director of the Structural Heart Program at the Mount Sinai Health System and Professor of Cardiovascular Surgery at the Icahn School of Medicine at Mount Sinai in New York. He has performed over 2000 cases of transcatheter aortic valve replacement (TAVR), transcatheter mitral valve repair (MitraClip), transcatheter mitral valve replacement, and tricuspid valve repair… View more
Chad Kliger
Job title: Director, Structural Heart Disease of Cardiovascular Medicine
Division of Structural and Congenital Heart Disease, Lenox Hill Heart and Vascular Institute – North Shore/LIJ Health System, New York, US. Dr Chad A Kliger serves as Associate Editor for US Cardiology Review. View more
Contemporary Management of Secondary Mitral Regurgitation
Author(s): Kashish Goel , Colin M Barker , JoAnn Lindenfeld Added: 3 years ago
Heart failure (HF) is a growing epidemic, with an estimated 6.2 million adults (≥20 years) affected between 2013 and 2016 in the US.1 The prevalence is increasing and is expected to reach 8 million by 2030.1 Mitral regurgitation (MR) is common in HF patients, especially in those with ischaemia, left ventricular (LV) dysfunction or dilated cardiomyopathy. MR in the absence of structural… View more

Vascular Disease and Surgery

Heart Failure
image
Job title: Leiter der Klinik
Hendrik Treede is currently the Director of the Department of Cardiac Surgery at the Mid-German Heart Center, University Hospital Halle (Saale). Hendrik’s professional interests are minimally invasive mitral valve reconstruction, minimally invasive bypass surgery, transcatheter valve interventions, aortic valve repair and aortic surgery, and fully endoscopic atrial ablation. He graduated medical… View more